Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oruka Therapeutics Inc (ORKA)

Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oruka Therapeutics Inc 855 OAK GROVE AVENUE SUITE 100 MENLO PARK CA 94025 USA

https://orukatx.com Employees: 68 P: 650-606-7910

Sector:

Medical

Description:

Oruka Therapeutics Inc. is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka Therapeutics Inc., formerly known as ARCA biopharma Inc., is based in WESTMINSTER, Colo.

Key Statistics

Overview:

Market Capitalization, $K 3,002,305
Enterprise Value, $K 2,958,295
Shares Outstanding, K 49,543
Float, K 37,311
% Float 75.31%
Short Interest, K 3,644
Short Float 7.36%
Days to Cover 7.48
Short Volume Ratio 0.82
% of Insider Shareholders 24.69%
% of Institutional Shareholders 56.44%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -105,430 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -29,580 K
EBIT, $ -122,060 K
EBITDA, $ -126,980 K

Growth:

1-Year Return 809.14%
3-Year Return 152.25%
5-Year Return 50.30%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 92.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.45 on 03/12/26
Next Earnings Date 05/13/26
Earnings Per Share ttm -1.86
EPS Growth vs. Prev Qtr 18.18%
EPS Growth vs. Prev Year 8.16%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 09/03/24

ORKA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -25.48%
Return-on-Assets % -24.34%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.50
Book Value/Share 9.75
Interest Coverage -3.92
60-Month Beta -0.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.